High-End MRI: Added Science
Peter Jezzard1

1FMRIB Centre, University of Oxford, United Kingdom

Synopsis

The recent emphasis on value in medical imaging, and the ever greater strain on many nations’ healthcare budgets as their population ages, has focused attention on what MRI and other similarly expensive imaging technologies can deliver. This extends to scientific advances, where grant funding bodies need to be persuaded that limited money spent on expensive technologies will lead to important scientific insights. The talk overviews a number of areas where high-end MRI seeks to make concrete scientific contributions.

Introduction

The recent emphasis on value in medical imaging, and the ever greater strain on many nations’ healthcare budgets as their population ages, has focused attention on what MRI and other similarly expensive imaging technologies can deliver. This extends to scientific advances, where grant funding bodies need to be persuaded that limited money spent on expensive technologies will lead to important scientific insights.

Costs:

When specifically applied to magnetic resonance imaging scanners, a significant current expense is in the magnet itself, especially in the case of ultra-high-field systems, where the amount of superconducting wire needed scales non-linearly with field strength. Also, the ‘standard’ alloy that is usually used as the wire in super-conducting magnets, copper combined with niobium-titanium, does not operate as effectively above about 10 Tesla, where either extra effort must be made to cool the wires so that they can operate at slightly higher fields, or different (and more complex/expensive) superconducting wires such as copper combined with niobium-tin must be used.

Ultra-high field:

Increasing the field strength leads to a corresponding increase in signal-to-noise ratio, which can be used in a variety of ways, including improving the spatial resolution of the image (Polimeni et al, 2010; Yacoub et al. 2008), or the spectral separation of an MRS experiment (Berrington et al. 2018), or the acquisition of time-limited data in less time. Examples of novel scientific insights that have been obtained at ultra-high field include exquisite cortical fMRI, enabling the directionality of input and output flows of information via prior anatomical layer information; or the activity of single (large) cells in a high-field pre-clinical system (Radecki et al. 2014). Even higher field MRI systems are proposed, albeit requiring funding at a national level to be realized.

Improved gradient technology:

An alternative tactic to gaining improved scientific insights is in the use of specialist gradient coil technology. For example, three human Connectom magnets (Setsompop et al. 2013), which incorporate advanced gradient coils offering 300mT/m gradient strength, have been deployed to sites in the USA and Europe. These gradient strengths allow far higher b-values than usually achievable, to study white matter (and grey matter) connectivity using diffusion MRI. These scanners have led to new insights into sheet-like axonal connections close to the cortex. An alternative approach to improving gradient technology is to focus on improving the gradient slew rate (Foo et al. 2018), for which improved echo-train characteristics can be achieved. Ultimately, slew rate improvements are limited by peripheral nerve stimulation (and eventually by cardiac stimulation), but high slew rates of up to 700 T/m/s can be achieved in head-dedicated MRI scanners.

Hyperpolarized MRI:

The main motivation for increasing the field strength of an MRI scanner (with the attendant cost implications outlined above) is to gain additional equilibrium magnetization and hence signal-to-noise ratio. For protons, the effective magnetization available (spins aligned with the static field versus spins aligned against the static field) for 1H spins at room temperature improves from 5.1x10-6 at 1.5 Tesla to 2.4x10-5 at 7 Tesla. Nevertheless, the effective fraction of possible spins contributing signal remains very small. A strategy to address this is to polarize the spin system externally and then inject or otherwise introduce the hyperpolarized agent into the body. Both liquid-state (13C using dissolution dynamic nuclear polarization) and gas-phase hyperpolarized agents (3He and 129Xe using optical pumping) have been developed. These offer substantial increases in the available polarization (>1000X), albeit with a lifetime limited by the T1 relaxation of the agent once injected/inhaled in vivo. As well as important biomedical applications, a number of scientific insights have also been made using hyperpolarized agents, such as being able to gain insights into very specific flux pathways (Timm et al. 2017), cell necrosis (Gallagher et al. 2009) or inflammation (Lewis et al. 2018).

High-N MRI:

A number of exciting projects have been funded to study large cohorts of subjects. Prominent examples of this phenomenon include the NIH-funded Human Connectome Project, the EU-funded Developing Human Connectome Project, and the MRC/Wellcome-funded UK Biobank Imaging Extension. These studies have provided substantial new insights into brain connectivity, and associations between imaging phenotypes, lifestyle and genetics (Miller et al. 2016).

Acknowledgements

No acknowledgement found.

References

Berrington A, Voets NL, Larkin SJ, de Pennington N, Mccullagh J, Stacey R, Schofield CJ, Jezzard P, Clare S, Cadoux-Hudson T, Plaha P, Ansorge O, Emir UE. A comparison of 2-hydroxyglutarate detection at 3 and 7 T with long-TE semi-LASER. NMR Biomed. 2018;31(3) in press

Foo TKF, Laskaris E, Vermilyea M, Xu M, Thompson P, Conte G, Van Epps C, Immer C, Lee SK, Tan ET, Graziani D, Mathieu JB, Hardy CJ, Schenck JF, Fiveland E, Stautner W, Ricci J, Piel J, Park K, Hua Y, Bai Y, Kagan A, Stanley D, Weavers PT, Gray E, Shu Y, Frick MA, Campeau NG, Trzasko J, Huston J 3rd, Bernstein MA. Lightweight, compact, and high-performance 3T MR system for imaging the brain and extremities. Magn Reson Med. 2018 in press

Gallagher FA, Kettunen MI, Hu DE, Jensen PR, Zandt RI, Karlsson M, Gisselsson A, Nelson SK, Witney TH, Bohndiek SE, Hansson G, Peitersen T, Lerche MH, Brindle KM.Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci U S A. 2009;106(47):19801-6.

Lewis AJM, Miller JJ, Lau AZ, Curtis MK, Rider OJ, Choudhury RP, Neubauer S, Cunningham CH, Carr CA, Tyler DJ. Noninvasive Immunometabolic Cardiac Inflammation Imaging Using Hyperpolarized Magnetic Resonance. Circ Res. 2018;122(8):1084-1093.

Miller KL, Alfaro-Almagro F, Bangerter NK, Thomas DL, Yacoub E, Xu J, Bartsch AJ, Jbabdi S, Sotiropoulos SN, Andersson JL, Griffanti L, Douaud G, Okell TW, Weale P, Dragonu I, Garratt S, Hudson S, Collins R, Jenkinson M, Matthews PM, Smith SM. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci. 2016;19(11):1523-1536.

Polimeni JR, Fischl B, Greve DN, Wald LL. Laminar analysis of 7T BOLD using an imposed spatial activation pattern in human V1. Neuroimage. 2010;52(4):1334-46.

Radecki G, Nargeot R, Jelescu IO, Le Bihan D, Ciobanu L. Functional magnetic resonance microscopy at single-cell resolution in Aplysia californica. Proc Natl Acad Sci U S A. 2014;111(23):8667-72.

Setsompop K, Kimmlingen R, Eberlein E, Witzel T, Cohen-Adad J, McNab JA, Keil B, Tisdall MD, Hoecht P, Dietz P, Cauley SF, Tountcheva V, Matschl V, Lenz VH, Heberlein K, Potthast A, Thein H, Van Horn J, Toga A, Schmitt F, Lehne D, Rosen BR, Wedeen V, Wald LL. Pushing the limits of in vivo diffusion MRI for the Human Connectome Project. Neuroimage. 2013;80:220-33.

Timm KN, Hu DE, Williams M, Wright AJ, Kettunen MI, Kennedy BW, Larkin TJ, Dzien P, Marco-Rius I, Bohndiek SE, Brindle KM. Assessing Oxidative Stress in Tumors by Measuring the Rate of Hyperpolarized [1-13C]Dehydroascorbic Acid Reduction Using 13C Magnetic Resonance Spectroscopy. J Biol Chem. 2017;292(5):1737-1748.

Yacoub E, Harel N, Ugurbil K. High-field fMRI unveils orientation columns in humans. Proc Natl Acad Sci U S A. 2008;105(30):10607-12.

Proc. Intl. Soc. Mag. Reson. Med. 26 (2018)